Ads
related to: moderna stockinvesco.com has been visited by 100K+ users in the past month
Search results
3 Reasons to Buy Moderna Stock
The Motley Fool via AOL· 10 hours agoThough that still trails the S&P 500, Moderna should be able to generate solid returns for a long time to patient investors. Should you invest $1,000 in ...
Moderna, Inc.'s (NASDAQ:MRNA) large institutional owners must be happy as stock continues to...
Simply Wall St. via Yahoo Finance· 7 hours agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna director Noubar Afeyan sells over $2.2m in company stock By Investing.com
Investing.com· 21 hours agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has recently sold a substantial number of shares...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 5 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 2 days agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 5 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 5 days agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
Moderna CFO sells $97,237 in stock amid performance unit vesting By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) reported a recent transaction by Chief Financial Officer James M. Mock,...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 1 day agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
